chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she also has PHN; 1st dose of Shingrix on 03 Jul 2021, 2nd not received; This case was reported by a consumer via call center representative and described the occurrence of post herpetic neuralgia in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number 4Y2P4, expiry date 23rd January 2023) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included cancer. Previously administered products included Zostavax and COVID BOOSTER 2021. Concurrent medical conditions included shingles (developed shingles on 25th May 2022).   On 3rd July 2021, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced post herpetic neuralgia and incomplete course of vaccination. On an unknown date, the outcome of the post herpetic neuralgia was not recovered/not resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the post herpetic neuralgia to be related to Shingrix.  Additional Information: GSK Receipt Date: 21-Jul-2022. Reporter's Comments: The case was self-reported by the patient. The patient received 1st dose of Shingrix on right arm. The patient stated that she had not yet had her second dose.  The patient stated the shingles were on the left side of her head, eye, and she also had PHN (post herpetic neuralgia). The reporter consented to follow up with HCP (pharmacy). Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. VAERS details were reported for 1st dose.
Patient received the hepatitis A (HAVRIX) vaccine the morning of 7/24/08.  Eighteen to twenty-four hours later he broke out in a morbilliform drug-reaction like rash on his chest, abdomen, back, upper arms + upper thighs.
coughing; weakness; chills; pyrexia; This spontaneous case was reported by a health care professional and describes the occurrence of COUGH (coughing), ASTHENIA (weakness), CHILLS (chills) and PYREXIA (pyrexia) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Arrhythmia. Concurrent medical conditions included Atrial fibrillation (IRREGULAR HEART BEAT 122). Concomitant products included APIXABAN (ELIQUIS), LETROZOLE, DONEPEZIL, DILTIAZEM, DIGOXIN, CITALOPRAM and LEVOCETIRIZINE for an unknown indication.   On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced COUGH (coughing), ASTHENIA (weakness), CHILLS (chills) and PYREXIA (pyrexia). At the time of the report, COUGH (coughing), ASTHENIA (weakness), CHILLS (chills) and PYREXIA (pyrexia) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.6 (Inconclusive) Patient's body temperature of 100.6 degrees Fahrenheit..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication information was reported.
pt recvd vax & had blotchy rash; pt devel cough & rash itches; treated w/DPH & oatmeal baths
89-year-old female with past medical history of HFpEF, severe tricuspid regurgitation with pulmonary hypertension and right-sided heart failure, atrial fibrillation on Coumadin, iron deficiency anemia, chronic kidney disease stage 3a, liver cirrhosis, hypertension, recent admission 1/10/2023 to 1/19/2023 for  Fall s/p left femur fracture and had intramedullary rod placement on 1/11/2023.  Her course was complicated by hyponatremia and postoperative blood loss for which she required blood transfusions.  Her hyponatremia was thought to be due to hypovolemic hyponatremia with component of SIADH from postoperative pain and she was on salt tablets which were stopped on 1/17/2023.  Coumadin resumed.  Patient was sent to rehab facility. Patient's sodium was being monitored outpatient and  She had Na of 126 on 1/30/23 and repeat sodium yesterday 121.  She was therefore transferred to ED for dyspnea on exertion and LE edema and 30# weight gain. Weight of 150 lbs on 1/11/23 and 184 lbs on 1/30/2023.   She tested positive for Covid but no cough and no hypoxia. Started on Remdesivit 2/3-2/7 last dose12:30 pm. Admitted for diuresis on lasix gtt. Much improved, renal function stable. 12L urine output from admission to 2/6. Change to oral lasix 80 mg BID 2/6 to see if will continue to respond well on orals. She could probably go home on 40 mg BID with extra 0.5 tablet of 80 mg lasix if shortness of breath, LE edema, 2# weight gain.  Patient hoping to go home 2/7/2023.  Isolation through 2/12/2023
Acute chronic shoulder pain, acute pain in wrists and hands, acute pain in feet, extreme fatigue, brain fog, loss of balance, diagnosed rheumatoid arthritis
No adverse reactions noted. Client was administered Kinrix( Dtap and IPV) combination vaccine.  Vaers report is being made due to the client's age at time of vacciation.
Case previously recorded as MA2009-5707. We received the following information from a Medical Center via MedCom, on 24 NOV 2009. This patient, age and date of birth unknown, was vaccinated with S-OIV FLUVIRIN (batch number unknown) subcutaneously on an unknown date. The vaccine was inadvertently administered subcutaneously (vaccine was supposed to be administered intramuscularly). Patient information was refused to the reporter. Patient outcome was not applicable, as there was no event. Agency Reference no.: NA09-008762.
Patient was administered the Pfizer BioNtech Covid vaccine (1st dose).  Within 3-5 of receiving the vaccine and while being observed, the patient fainted. Patient breathing was slower than normal and the patient was perspiring heavily.  The patient was administered a dose of EpiPen which temporarily alleviated the slower breathing, but the patient appeared to go in and out of consciousness. Paramedic eventually arrived and took the patient to the ER
Pt received a blood draw, and then about 2-3min later, 2nd HPV given in the RA. I completed discharge directly after and asked adults in room if there were any questions. As I finished, pt began to slump forward and eyes rolled in the back of her head. Arms and legs stiffened and mouth slightly contorted. Lasted no more than about 5sec. Pt sat up and asked what happened. Vital signs taken and within normal limits. Pt had eaten 4hours prior. After pt calmed down, she commented, "I felt the pain of the shot and I got really really scared. Then I got really dizzy. I don't remember what I did."
Headache; This is a spontaneous report from a non-contactable other healthcare professional.  A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Lot number: EK9231, via an unspecified route of administration from 31Dec2020 08:30 to 31Dec2020 08:30 as single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced headache on 01Jan2021 07:30 with outcome of recovered.  No treatment received.  No follow-up attempts are possible. No further information is expected.
The technician did not draw back the needle after it was inserted in my deltoid muscle.  Once the needle was withdrawn, I immediately began to bleed.  I felt warmth, and a heaviness travel down my left arm.  The same sensation traveled to my right arm.  I felt the vaccine move through the left side of my abdomen, then across my chest, starting on the right side of my chest, before reaching the left side of my chest.    2-days later, I had scattered areas of bruising in random areas all over my body.  I experienced intermittent loss of taste and smell.  On the 3rd day, I was unable to bear weight on my left leg.  Within 24-hours, this resolved.  The intermittent loss of taste and smell resolved after 4-days.  9-days after the vaccination, I began to experience copious lacrimation from the right and left eyes.  I was diagnosed with COVID conjunctivitis 5-days later.
Diarrhea; nausea; vomiting; GI Upset; This is a spontaneous report from a contactable physician and consumer. A 69-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13; lot number and expiration date: unknown), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced diarrhea, nausea, vomiting, GI upset on 30Dec2016. Outcome of the events was unknown.  Information on lot/batch number has been requested.
Suspected vaccination failure; Had shingles after I got the vaccine; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication.  The patient had got shingles after receiving the vaccine. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and lab test confirmation was unknown at the time of reporting.
Shooting pain in arm, extreme soreness and weakness in arm and shoulder, shoulder joint cracking, trouble lifting arms, muscle strain.
This spontaneous report as received from   a pharmacist refers to an 83 year old male patient with no known pertinent medical history and no known drug reactions/allergies. There was no concomitant medication. On 29-JUL-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot # J001010, exp date 24-APR-2014), subcutaneous. The pharmacist reported that the patient presented to the pharmacy on 02-AUG-2013 with "7 randomly placed (no pattern) shingles-like vesicles on his abdomen". The pharmacist reported that the patient was not experiencing any symptoms at the site of the vesicles but did experience "a great deal of itching" at the injection site immediately following the ZOSTAVAX administration. No lab diagnostics studies were performed. The pharmacist reported that the injection site itching had disappeared but the rash on the abdomen remains. VZVID packet faxed. Additional information has been requested.
Patient had negative rubella titer and as part of pre-employment she received MMR vaccine on 10-19-2005.  Moderate to severe bilateral wrist/hand arthralgia began ten days later and lasted about 3 weeks, from 10-29-05 until about 11-21-05.  This pain was not accounted for by any activity at work or at home.  No prior history of such symptoms.  Previously healthy with no chronic meds or medical conditions.  She also had mild bilateral knee and ankle pain for a portion of this time.  Pain was fairly well-controlled with OTC ibuprofen.
PVCs started on 12/29/2022; no treatment at this time; not continuous like the last two events (first event I had bigemeny at times and had a full cardiac workup, PVCs went away 6 months later and the second event only lasted a week), just lasts an hour or so
very very sick and was sick all day; Initial information received on 08-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional.  This case involves patient (unknown demographics) who got very very sick and was sick all day (illness), when received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious very very sick and was sick all day (illness) unknown latency following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown for illness.
Pt c/o dizziness, vomiting, diarrhea, nausea & feeling clammy; family called 911 thinking pt was having a heart attack; pt dx in ER as having labyrinthitis; pt blaming flu shot as the cause;
Rash over entire upper trunk except underneath bra. Facial edema. Nail beds cyanotic. Rash appears to be progressing. Oxygen given as well as 50 mg Benadryl IM. Transferred to ER. Was given Phenergan and Steroid IV and Benadryl IM around 2:30 PM. Discharged around 4 PM. Was told not to have vaccinations together anymore, because could not tell which one caused the allergic reaction. 10/15/03: Call to pt. She states had mild difficulty swallowing last PM and some itching today but generally improved. She called her MD and was advised to continue Benadryl until asymptomatic.
A HUGE REACTION THAT LASTED OVER TWO WEEKS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included: allergies, and other pre-existing medical conditions included: The patient experienced unspecified reaction due to unspecified medication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced a huge reaction that lasted over two weeks. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from a huge reaction that lasted over two weeks. This report was non-serious.
Measles; hive rash all over my body; hive rash all over my body; This is a spontaneous report from a non-contactable consumer (patient). A 34-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided) via an unspecified route of administration, administered in left arm on 04Apr2021 as a single dose for COVID-19 immunisation. Medical history included Lupus and fibromyalgia. There were no concomitant medications. The patient previously took azithromycin and immunoglobulins and experienced allergies. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient experienced measles and had hive rash all over her body on 07Apr2021. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. Treatment was given in response to the events which included prednisone and allergy medicine. The patient has not been tested for COVID-19 post vaccination. The outcome of the events was not recovered.   Information about lot/batch number has been requested.
Immediately following vaccination at 0840, patient walked out to nursing station to receive vaccination record, when she fainted, hitting her forehead on the counter and falling to the floor. She exhibited appoximately 15 seconds of generalized tonic-clonic seizure activity, then became responsive within the next 15 seconds. Face mask O2 was administered, despite an O2 saturation of 94%, HR 70. She remained supine while a blood glucose was obtained with difficulty due to vasoconstriction of peripheral extremities. Glucose approximately 10 minutes post-event of 88g/dL. VS 15 minutes post-event in sitting position: T 98.0, BP 104/64, P75, O2 sat 97%. Electrolyte solution offered PO. 45 minutes post-event, patient discharged in stable condition.
This spontaneous report as received from a physician refers to a 19 year old patient. The patient's relevant medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with the appropriate primary dose of VAQTA 25/0.5 (units not provided) (lot number, expiration date, dose and route were not reported). On an unspecified date, the patient received the booster dose of VAQTA Pediatric Formulation, second in the two-dose series (dose, route, lot# and expiry date were not reported). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pain at injection site; left facial discomfort like sinus pressure; frequent urination 48 hours after vaccinations.
This spontaneous report as received from a pharmacist refers to a 62 year old female patient with no pertinent medical history/drug allergies or drug reactions reported. On 09-AUG-2013, the patient was vaccinated with a dose of ZOSTAVAX, (route, anatomical location, lot# and expiration date were not reported). On 10-APR-2015, the patient was vaccinated with another dose of ZOSTAVAX, subcutaneous (lot# reported as L003216 expiration date 30-APR-2016). There was no concomitant therapy reported. On 12-APR-2015, the patient experienced injection site swelling and injection site warmth reported by the pharmacist as large, swollen, warm area at the site injection. No laboratory tests were performed. The patient sought a medical attention by called the pharmacist. The outcome of injection site swelling and injection site warmth was reported as recovering/resolving. Additional information has been requested.
p/vax pt noticed 5" circle of redness, firmness & warmth on upper lt deltoid area;some tenderness when touched;tx w/cold packs to affected area & APAP alternating w/advil;redness, warmth & firmness cont;
Pain at injection site, Dizziness, fever, chills, all over muscle pain, Headache, left armpit lymph node swelling and soreness
6 hours of not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (6 hours of not feeling well) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MALAISE (6 hours of not feeling well). On 05-Feb-2021, MALAISE (6 hours of not feeling well) had resolved.   Action taken with mRNA-1273 in response to the events was not applicable     No concomitant medications were reported.  No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: follow-up was received on 20-MAY-2021 which had no new information.
The shot was taken at the same time as my influenza vaccine. I have never reacted to either type of vaccine separately. However when I took both vaccines at the same time I broke out into hives and had an itchy throat.
Pt. did not have any adverse events. Pt. made appointment for covid vaccine first dose and was given Moderna for 1st dose instead of Pfizer. On 07/21/2021 pt. needed second dose of Covid and she got her second Moderna dose intramuscularly in L deltoid. Pt. did not report any adverse events or reaction. Pt. had a Well Child Check on 08/10/2021 with PCP and pt. did not report any side effects or problems.
Approx 12 hours post injection woke in night with chills and fever. 101.5F fever persisted through the following morning until early afternoon. Flu-like symptoms; fever, body aches, low appetite, fatigue, chills. High fever reduced with acetaminophen. Bed rest through afternoon and fluids. Body aches and fever dissipated by 36 hours post injection. Return to normal health by 48 hours.
Information has been received from a licensed practical nurse concerning multiple unspecified patients of unknown age and gender. The patients medical history, concurrent condition and concomitant therapy were not provided. On unknown dates, the patiens were vaccinated with doses of improperly stored RECOMBIVAX HB (lot #, dose and route unspecified). No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
Patient starting experience itching and redness on her left arm 5-10 minutes after receiving the vaccination
Erythema, warmth, itching at site of injection developing 1 week after injection.
Pt. states developed fever 7/25/12 pm - did not take but knew she felt hot. Very achy, hot & raised induration 4"x3" on back of arm. Talked with her on 7-27-12 & told her to apply cold compresses, take TYLENOL Ibuprofen. As directed - she can also take --> one antihistamine - called back 7/30 - client doing better - did not follow any of my instructions. She was out gardening, she took ASA & did not apply cold compresses.
Information has been received from a registered nurse concerning a 15 month old male who on 30-NOV-2007 was vaccinated with a dose of PEDVAXHIB (OMPC) (Lot #657380/0377U).  Concomitant therapy included montelukast sodium (MSD).  On 11-DEC-2007 the patient experienced a localized reaction.  The nurse described the reaction as a "strawberry" size and reaction.  Unspecified medical attention was sought.  At the time of the report the patient's outcome was unknown.  Additional information has been requested.
The Prevnar13 vaccine, given 4/20/2020, was very painful and I could not move my arm, then I nearly fainted. It took several minutes to be able to sit up and several more minutes to be able to walk and I could move my arm, but it hurt badly. The muscles were weak, the shoulder was swollen a bit (no bruising). I also had slight nausea for a week, with a little fatigue and a slight headache. It was 2-1/2 weeks before the pain and weakness in my arm was nearly gone. There is still a bit of pain at times. I did report this to my physician.
Administered flu shot, applied bandaid, patient said she felt dizzy, I told her to remain in seat, she leaned over & passed out. She was out for about 5-10 seconds. Mother stated she had passed out 4-6 wk ago sitting at beauty parlor. EMS was called & responded. Patient was checked out in ER and said she was OK.
I woke up in the early morning with dizziness and nausea and passed out on the floor.  My husband called 911 and I as transported by ambulance to the hospital, I was admitted and remained there for two days.  My doctor increased my Carvedilol dose and added Flecainide as well as a  Clonodine patch to try to control it.  Since then my heart rate is mostly okay but my blood pressure is still unstable.